A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)

Clinical trial NCT06741228 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06741228
Sponsor: Definium Therapeutics US, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2024-12-11
Primary completion: 2026-07-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.